Our previous data demonstrated that Ras activation was necessary and sucient for transforming growth factor-b (TGFb)-mediated Erk1 activation, and was required for TGFb up-regulation of the Cdk inhibitors (CKI's) p27 Kip1 and p21
and p21
Cip1 (KM Mulder and SL Morris, J. Biol. Chem., 267, 5029 ± 5031, 1992 ; MT Hartsough and KM Mulder, J. Biol. Chem., 270, 7117 ± 7124, 1995; MT Hartsough et al., J. Biol. Chem., 271, 22368 ± 22375, 1996 and J Yue et al., Oncogene, 17, 47 ± 55, 1998 ). Here we examined the role of Ras in TGFb-mediated eects on a rat homolog of Smad1 (termed RSmad1). We demonstrate that both TGFb and bone morphogenetic protein (BMP) can induce endogenous Smad1 phosphorylation in intestinal epithelial cells (IECs) . The combination of transient expression of RSmad1 and TGFb treatment had an additive eect on induction of the TGFbresponsive reporter 3TP-lux. Either inactivation of Ras by stable, inducible expression of a dominant-negative mutant of Ras (RasN17) or addition of MAP and ERK kinase (MEK) inhibitor PD98059 to cells signi®cantly decreased the ability of both TGFb and BMP to induce phosphorylation of endogenous Smad1 in IECs. Moreover, either inactivation of Ras or addition of PD98059 to IEC 4-1 cells inhibited the ability of RSmad1 to regulate 3TP luciferase activity in both the presence and absence of TGFb. Collectively, our data indicate that TGFb can regulate RSmad1 function in epithelial cells, and that the Ras/MEK pathway is partially required for TGFb-mediated regulation of RSmad1.
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Transforming growth factor b (TGFb) is an endogenous cytokine that regulates cell growth, dierentiation, adhesion, early embryonic development, and extracellular-matrix protein synthesis (Hartsough and Mulder, 1997) . The signaling receptors for TGFb (R I and R II ) and other related factors are expressed at the cell surface; they are activated when they form a heteromeric complex and are phosphorylated at Ser/ Thr residues (Hartsough and Mulder, 1997; Derynck, 1994; MassagueÂ , 1996) . Recently, genetic studies in Drosophila have resulted in the identi®cation of genes required for the function of the TGFb superfamily member decapentaplegic (Dpp) (Raftery et al., 1995) . Mammalian homologs of these signaling factors for Dpp, termed Sma and Mad homologs (Smads) have also been cloned (Hartsough and Mulder, 1997; MassagueÂ , 1996; Derynck and Zhang, 1996; Heldin et al., 1997; Wrana and Attisano, 1996; Yue et al., in press ). However, the precise mechanism for regulation of the Smads by the TGFb superfamily members has not been fully elucidated.
Previously, we reported that TGFb growth inhibitory activity was associated with a rapid and direct activation of Ras and of Erk1 in TGFb-sensitive untransformed epithelial cells (Mulder and Morris, 1992; Hartsough and Mulder, 1995) . Moreover, TGFb aected a sustained activation of Erk2 and of stressactivated protein kinases (SAPKs)/c-Jun N-terminal kinases (JNKs) that was directly correlated with the growth inhibitory eects of TGFb in human breast cancer cells (Frey and Mulder, 1997a,b) . We have also reported that stable, inducible expression of a dominant-negative mutant of Ras (RasN17) resulted in a reversal of the ability of TGFb to decrease both Cdk2 activity and cyclin A protein expression in intestinal epithelial cells (IECs) (Hartsough et al., 1996) ; RasN17 completely blocked TGFb-mediated activation of Erk1 (Hartsough et al., 1996) and upregulation of the CKIs p21
Cip1 and p27 Kip1 (Yue et al., 1998) .
In light of our previous data and the evidence demonstrating the importance of the Smad pathway for TGFb signaling, it was of interest to determine whether the Ras/MEK pathway was involved in TGFb-mediated regulation of RSmad1 in IEC 4-1 cells. Our data indicate that TGFb can phosphorylate endogenous Smad1, and that expression of RSmad1 can stimulate the TGFb-responsive reporter 3TP-Lux in the presence of TGFb. More importantly, however, our results demonstrate that inactivation of the Ras/ MEK pathway signi®cantly decreased both TGFbmediated phosphorylation of Smad1 and RSmad1-induced 3TP luciferase activity. Thus, TGFb can signal through RSmad1, and cross-talk between the Ras/ MEK and RSmad1 signaling pathways for TGFb exists.
The requirement of Ras for phosphorylation of Smad1 by TGFb
Previous studies involving expression of exogenous, epitope-tagged Smad1 suggested that Smad was generally involved in BMP, but not TGFb, signaling (Liu et al., 1996; Kretzschmar et al., 1997a; Hoodless et al., 1996) . However, it is not clear whether endogenous Smad1 is regulated by TGFb in TGFb-sensitive epithelial cells. We have cloned a rat homolog of Smad1 (RSmad1) by screening a cDNA library constructed from the highly TGFb-sensitive, untransformed rat IEC 4-1 cell line (Yue et al., 1999; Mulder et al., 1993) . We were interested in whether TGFb could regulate endogenous Smad1 phosphorylation in the IEC 4-1 cells from which the cDNA library was constructed. For these experiments, we used BMP2 as a positive control.
The speci®city of the anti-Smad1 antibody used in our studies has been described previously (Kretzschmar et al., 1997a) . We have also shown that this Smad1 antibody does not recognize RSmad1 mutated at the four Erk consensus phosphorylation sites in the linker region of Smad1, although it recognizes wild-type RSmad1 (data not shown). Our result may indicate that this Smad1 antibody recognizes a region near these sites. Similar sites are present in Smads 5 and 8. Thus, these data suggest that this Smad1 antibody does not cross-react with Smads other than Smads 5 or 8, and these two Smads migrate at dierent positions than does Smad1 (Chen et al., 1997; Nishimura et al., 1998) .
As shown in Figure . Thus, our data suggest that TGFb phosphorylation of endogenous Smad1 is mediated by TGFb-speci®c binding proteins. Although two groups previously reported that TGFb could phosphorylate endogenous Smad1 (Lechleider et al., 1996; Yingling et al., 1996) , the antibodies employed in their systems were not speci®c for Smad1.
As mentioned previously, we have demonstrated that Ras was partially required for the eects of TGFb on Cdk2 activity and cyclin A expression, whereas Ras was essential for TGFb-mediated activation of Erk1 and up-regulation of the CKIs p21
Cip1 and p27
Kip1 (Hartsough et al., 1996; Yue et al., 1998) . Hence, there appears to be a tight link between the cell cycle eects of TGFb and activation of the Ras/MAPK pathway. Since activation of the Smad pathway has been implicated in TGFb-mediated growth inhibition (Liu et al., 1997) , it was of interest to examine whether the Ras/MEK pathway was required for TGFbinduced phosphorylation of endogenous Smad1 in IEC 4-1 cells. Previously, we stably transfected the IEC 4-1 cells with a dominant-negative mutant of Ras (RasN17) under the control of an inducible metallothionein promoter, and selected several positive clones (E3, C5 and C6) (Hartsough et al., 1996) . Here, we cultured the E3 cells in the presence or absence of ZnCl 2 for 36 h to induce RasN17 expression and then treated the cells with TGFb 3 for 30 min. As shown in Figure 1b , both TGFb 3 and BMP2 resulted in a signi®cant increase in endogenous Smad1 phosphorylation in the absence of ZnCl 2 . Moreover, in similarity to the results observed in the parental IEC 4-1 cells, no basal Smad1 phosphorylation was observed in the E3 cells. In contrast, in the presence of ZnCl 2 , phosphorylation of Smad1 was signi®cantly decreased by 85% or 58% after treatment with either TGFb or BMP, respectively. However, despite the loss of endogenous Ras function, some Smad1 phosphorylation was still observed after ligand addition. Our results suggest that Ras/MEKindependent mechanisms also contribute to the phosphorylation of Smad1 by TGFb or BMP. Thus, both ligands can phosphorylate endogenous Smad1, and Ras/MEK pathway is partially required for these ligand-dependent events. 5 cells/cm 2 in T-25¯asks in SMIGS medium. The next day, IEC 4-1 cells were washed twice with PBS to remove serum components and were incubated in serum-free DMEM medium for 13 h. This treatment does not render the cells quiescent (Mulder and Morris, 1992; Mulder et al., 1993) . Cells were then washed twice with PBS, and were labeled with 32 Porthophosphate (1 mCi/ml) for 3 h in phosphate-free DMEM. Cells were subsequently treated with TGFb 3 (10 ng/ml) or BMP2 (50 ng/ml) for the indicated times. Samples were normalized for radioactivity as determined by TCA precipitation, and were incubated with 1 ml of anti-Smad1 antibody (Kretzschmar et al., 1997a ) for 1 ± 2 h at 48C. Immunocomplexes, collected by protein A-Sepharose, were washed ®ve times with EBC buer, and were resolved by 15% SDS ± PAGE. Gels were Coomassie-stained, dried and exposed to X-ray ®lm at 7708C (Yue et al., 1998) . (b) Eect of induction of RasN17 on TGFb 3 -or BMP2-mediated phosphorylation of endogenous Smad1. RasN17 E3 cells were plated as for IEC 4-1 cells in (a). The next day, cells were incubated in basal medium (SM) without serum in the presence or absence of ZnCl 2 for 36 h to induce RasN17 expression. This protocol was previously shown to induce RasN17 to levels sucient to block signaling through wild-type Ras (Hartsough et al., 1996; Yue et al., 1998 ). RasN17 E3 cells were then labeled with 32 P-orthophosphate, and immunoprecipitation was performed as described for IEC 4-1 cells in (a)
Requirement of Ras for Smad1-mediated 3TP-Lux regulation
The current model for activation of the Smad1 pathway suggests that ligand-dependent phosphorylation may lead to regulation of gene transcription in the nucleus (Hartsough and Mulder, 1997; Heldin et al., 1997) . Accordingly, it was on interest to determine whether Smad1 could regulate transcriptional events and if so, whether the Ras/MEK pathway could participate in such events. For these studies, cells were transiently transfected with the RSmad1 that we cloned from an IEC cDNA library (Yue et al., 1999) , together with the TGFb-responsive luciferase reporter, p3TP-Lux (Wrana et al., 1992) . 3TP-Lux contains three AP-1 sites and 400 bp of the PAI-1 promoter (Wrana et al., 1992) . Although 3TP-lux does not represent a minimal Smad regulated site, and is regulated by growth factors in addition to TGFB through the Smad components (Yingling et al., 1997; De Caestecker et al., 1998) , it is still a useful indicator of general TGFb responsiveness.
As shown in the left panel of Figure 2 , TGFb increased 3TP luciferase activity, and ZnCl 2 treatment, alone, did not cause any signi®cant change in 3TP luciferase activity either in the presence or absence of TGFb. As shown in the right panel of Figure 2 , expression of RSmad1 by transient transfection potentiated the ability of TGFb to induce 3TP luciferase activity in RasN17 E3 cells. Moreover, the induction of RasN17 by ZnCl 2 treatment decreased the ability of RSmad1 to induce 3TP luciferase activity in the presence of TGFb by 40% (Figure 2, right panel) . These results indicate that Ras is partially required for the RSmad1-mediated 3TP luciferase induction in intestinal epithelial cells.
Requirement of MEK for Smad1 regulation by TGFb
It was also of interest to determine whether MEK1, a downstream component of Ras, was involved in Smad1 phosphorylation and RSmad1-mediated transcriptional regulation by TGFb. For these studies, we employed the MEK1 inhibitor PD98059 to block Erk1 activation by TGFb in IEC 4-1 cells. As shown in Figure 3a , Erk1 was activated by twofold within 30 min of TGFb 3 addition to IEC 4-1 cells. Addition of the MEK1 inhibitor PD98059, at concentrations of either 10 mM or 15 mM, completely inhibited the ability of TGFb 3 to activate Erk1. Thus, PD98059, at a concentration of 10 mM could be used to determine whether MEK1 was involved in Smad1 regulation by TGFb. Similar results were obtained for BMP (data not shown).
We have examined the eect of PD98059 on Smad1 phosphorylation by TGFb and BMP. As shown in Figure 3b , addition of the MEK1 inhibitor PD98059 (10 mM) resulted in a 57% or 65% inhibition of Smad1 phosphorylation by TGFb or BMP treatment, respectively. Hence, our data indicate that MEK is partially required for Smad1 phosphorylation by both ligands.
We have also examined whether MEK was involved in RSmad1-mediated transcriptional regulation. As depicted in the left panel of Figure 3c , TGFb 3 increased 3TP luciferase activity, and PD98059, alone, did not have a signi®cant eect on 3TP luciferase activity either in the absence or presence of TGFb. As shown in the right panel of Figure 3c , expression of RSmad1 in the parental IEC 4-1 cells induced 3TP luciferase activity, and potentiated the ability of TGFb to induce 3TP activity. Addition of the MEK1 inhibitor PD98059 decreased the ability of RSmad1 to induce 3TP activity both in the absence and presence of TGFb, by 30% or 40%, respectively (Figure 3c, right panel) . These data demonstrate that MEK1 is also partially required for RSmad1-induced 3TP luciferase activity in IEC 4-1 cells. The ability of both TGFb and RSmad1 to regulate 3TP luciferase activity in the IEC 4-1 cells (Figure 3c ) was greater than that in the N17E clone (Figure 2 ). This dierence may be due to leaky expression of the RasN17 in the E 3 clone.
It is noteworthy that both RasN17 and PD98059 were able to inhibit 3TP-Lux activity induced by TGFb addition in the presence of exogenous RSmad1 expression, yet blockade of this induction was not observed in the absence of exogenous RSmad1 expression. These results suggest two additional points of potential interest. First, our current results are similar to our previous data indicating that a dominant-negative mutant of ERK2 did not inhibit the ability of TGFb to stimulate 3TP-Lux activity (Frey and Mulder, 1997b) . Thus, our data suggest that the activation of the Ras/MEK pathway by TGFb may not directly regulate AP-1 activity, at least in the context of the 3TP-Lux reporter. Second, endogenous Smad1 should be aected by Ras/MEK blockade. However, in the absence of transfection of exogenous RSmad1, Figure 2 Ras is partially required for the eects of RSmad1 on the TGFb-responsive reporter 3TP-Lux. RasN17E3 cells (1610 6 cells) were electroporated (450 V, 960 mF) in SM with 0.5 mg of 3TP-Lux, 0.125 mg renilla luciferase control reporter (pRL-SV40) and 2.5 mg of either RSmad1 or empty vector pCGN. Twelve hours after transfection, cells were incubated in serum-free medium in the absence or presence of ZnCl 2 (100 mM) for 36 h. Thereafter, TGFb 3 (10 ng/ml) was added and luciferase activity was measured 24 h after TGFb treatment using the Dual luciferase assay (E1910, Promega) according to the manufacturer's instructions. The results plotted represent the x+s.d. for triplicate transfections endogenous Smad 2 (which does not contain Erk consensus phosphorylation sites but is also activated by TGFb) may still regulate 3TP-Lux activity.
Collectively, our data herein demonstrate that both RasN17 and PD98059 partially inhibited the ability of RSmad1 to induce 3TP-Lux activity in both the absence and presence of TGFb. Although 3TP-Lux does not represent a minimal Smad regulated site, our results may still suggest that two parallel pathways emanate from the TGFb receptors to indirectly regulate 3TP-Lux activity. Activation of the Ras/ MEK pathway potentiates 3TP-Lux stimulation by the Smad pathway. Each pathway may also regulate additional signaling components that ultimately aect 3TP-Lux activity.
Concluding remarks
Our results prodvide the ®rst clear evidence of crosstalk between the Smad1 and Ras/MEK signaling pathways for TGFb in epithelial cells. Although At® and coworkers reported that activation of the SAPKs/JNKs was required for induction of 3TP luciferase activity after coexpression with Smad3 plus Smad4 in MDCK cells, TGFb did not activate the SAPKs until 8 h after TGFb addition to their system. Since the activation of the SAPKs was delayed in their system, the eects of these kinases on the ability of Smad3 plus Smad4 to regulate 3TP luciferase activity would be expected to be indirect. This is in contrast to the rapid (within 3 ± 30 min) activation of Ras, Erks, and SAPKS that we have shown here and reported previously (Mulder and Morris, 1992; Mulder, 1995, 1997; Frey and Mulder, 1997a,b) .
Our results also dier from a report which indicated that epidermal growth factor and hepatocyte growth factor (HGF) could phosphorylate Smad1 though an Erk-mediated pathway to inhibit BMP-mediated nuclear accumulation and transcriptional activation of Smad1 (Kretzschmar et al., 1997b) , However, this report did not examine the direct eects of BMP on Erk activation and subsequent Smad1 regulation. Here, we have demonstrated the direct activation of ERK both by TGFb (Figure 3a ) and BMP (data not shown). We have also demonstrated that Ras and MEK are partially required for Smad1 phosphorylation by both TGFb and BMP. Our results appear to be similar to the situation in Xenopus, for which BMP4 can regulate the Ras/Raf/AP-1 pathway (Xu et al., 1996) . In addition, we have demonstrated that Ras and MEK are partially required for the ability of TGFb to regulate Smad1 transcriptional eects on the 3TP-Lux reporter. Accordingly, consideration of the direct eects of TGFb superfamily members on the Ras/ Cell lysates were incubated with either an anti-Erk1 (SC-93) antibody or normal rabbit IgG (nonspeci®c control), and in vitro phosphorylation of myelin-basic protein (MBP) by Erk1 was analysed as described previously (Hartsough and Mulder, 1995) . Phosphorylated MBP was visualized by autoradiography. (b) Inhibition of TGFb 3 -or BMP2-mediated phosphorylation of Smad1 by the MEK1 inhibitor PD98059. IEC 4-1 cells were plated and treated as described in Figure 1a . Cells were labeled with 32 P-orthophosphate for 3 h. Cells were then treated with or without the MEK inhibitor PD98059 (10 mM) for 30 min and were subsequently treated with TGFb 3 (10 ng/ml) or BMP2 (50 ng/ml) for 15 min. Immunoprecipitation was performed as described in Figure 1a Inhibition of RSmad1-induced 3TP-Lux reporter activity by the MEK1 inhibitor PD98059. IEC 4-1 cells (1610 6 cells) were electroporated (450 V, 960 mF) in SM with 0.5 mg of 3TP-Lux, 0.125 mg renilla luciferase control reporter (pRL-SV40) and 5 mg of either RSmad1 or empty vector pCGN. TGFb 3 (10 ng/ml) was added 12 h after transfection in the presence or absence of the MEK inhibitor PD98059 (10 mM). Luciferase activity was measured as described for Figure 2 MEK pathway is necessary to fully interpret the results obtained from Smad signaling studies.
In summary, our results are consistent with a model for TGFb signaling whereby TGFb activates Ras and MAPKs. Ras and MAPKs are partially required for both TGFb-induced Smad1 phosphorylation and Smad1-mediated transcriptional regulation. Although Ras is necessary and sucient for TGFb regulation of the CKIs (Yue et al., 1998) , Ras/MEK-independent pathways are also required for Smad1 phosphorylation and transcriptional activation by TGFb. In addition, it is expected that other intersecting pathways are activated downstream of the TGFb receptors, each of which contributes to the diverse cellular outcomes of TGFb.
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